<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01131260</url>
  </required_header>
  <id_info>
    <org_study_id>HD36801-STAN</org_study_id>
    <secondary_id>U10HD021410</secondary_id>
    <secondary_id>U10HD027869</secondary_id>
    <secondary_id>U10HD027917</secondary_id>
    <secondary_id>U10HD053118</secondary_id>
    <secondary_id>U10HD027915</secondary_id>
    <secondary_id>U10HD034208</secondary_id>
    <secondary_id>U10HD053097</secondary_id>
    <secondary_id>U10HD040500</secondary_id>
    <secondary_id>U10HD040485</secondary_id>
    <secondary_id>U10HD040544</secondary_id>
    <secondary_id>U10HD040545</secondary_id>
    <secondary_id>U10HD040560</secondary_id>
    <secondary_id>U10HD040512</secondary_id>
    <secondary_id>U01HD036801</secondary_id>
    <secondary_id>U10HD068268</secondary_id>
    <secondary_id>U10HD068282</secondary_id>
    <nct_id>NCT01131260</nct_id>
  </id_info>
  <brief_title>Fetal ST Segment and T Wave Analysis in Labor</brief_title>
  <acronym>STAN</acronym>
  <official_title>A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic Fetal Heart Rate Monitoring (STAN)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The George Washington University Biostatistics Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Neoventa Medical</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>The George Washington University Biostatistics Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this research is to test a new instrument, called a fetal STAN monitor, that
      may be used during labor to monitor the electrical activity of the baby's heart. This new
      instrument is designed to help the doctor determine how well the baby is doing during labor.
      It will be used along with the existing electronic fetal monitor used to measure the baby's
      heart rate and the mother's contractions during birth. The specific purpose of this research
      study is to see if this new instrument (fetal STAN monitor) will have an impact on newborn
      health.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A Randomized Trial of Fetal ECG ST Segment and T Wave Analysis as an Adjunct to Electronic
      Fetal Heart Rate Monitoring (STAN):

      Fetal ECG analysis of the ST segment (STAN) is now FDA-approved and clinically available in
      the United States as an adjunct for the interpretation of electronic fetal heart rate
      patterns. There have been a number of randomized controlled trials as well as observational
      studies in Europe documenting utility of this modality in terms of reducing fetal acidosis at
      birth, and decreasing the need for operative vaginal delivery. However, despite these
      endorsements, there remain concerns with the application of the technology to the United
      States. None of the randomized trials were performed in the United States where patient
      case-mix and obstetrical practice, such as the use of fetal scalp pH, differ from Europe,
      which may affect the impact of this technology on perinatal outcomes. Moreover, the results
      of the European studies are not uniformly positive.

      This protocol describes a randomized controlled trial of the STAN technology as an adjunct to
      electronic fetal heart rate monitoring versus fetal heart rate monitoring alone.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>November 2010</start_date>
  <completion_date type="Actual">August 2014</completion_date>
  <primary_completion_date type="Actual">April 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>The study is a randomized, controlled clinical trial of 11,000 women in labor at &gt; 36.0 weeks gestation randomized to one of two groups using the STAN S31 system:
Fetal STAN electrode inserted and data available to caregivers (open device group)
Fetal STAN electrode inserted, but data masked to the caregivers (masked device group)</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Care Provider)</masking>
    <masking_description>The study is a randomized, controlled clinical trial of 11,000 women in labor at &gt; 36.0 weeks gestation randomized to one of two groups using the STAN S31 system:
Fetal STAN electrode inserted and data available to caregivers (open device group)
Fetal STAN electrode inserted, but data masked to the caregivers (masked device group)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Number of Participants With Primary Composite Outcome</measure>
    <time_frame>From Delivery through 1 month of age</time_frame>
    <description>Composite primary outcome of intrapartum fetal death, neonatal death, Apgar score &lt;=3 at 5 minutes, neonatal seizure, umbilical artery blood pH &lt;= 7.05 with base deficit &gt;=12 mmol/L in extra-cellular fluid, intubation for ventilation at delivery, neonatal encelphalopathy</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Intrapartum Fetal Deaths (Primary Outcome Component)</measure>
    <time_frame>During labor and through delivery of the baby</time_frame>
    <description>Death of the fetus during the intrapartum period.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Neonatal Deaths (Primary Outcome Component)</measure>
    <time_frame>Delivery through1 month of age</time_frame>
    <description>Death of the newborn between delivery and1 month of age</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Infants With Apgar Score &lt; = 3 at 5 Minutes (Primary Outcome Component)</measure>
    <time_frame>5 minutes after delivery</time_frame>
    <description>The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score. The lowest score is 0, the highest score is 10.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Infants Who Experienced Neonatal Seizure (Primary Outcome Component)</measure>
    <time_frame>Birth through hospital discharge</time_frame>
    <description>Number of infants who experienced Neonatal Seizure</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Infants With Umbilical-artery Blood pH &lt; = 7.05 and Base Deficit in Extracellular Fluid &gt; = 12 mmol/Liter (Primary Outcome Component)</measure>
    <time_frame>Delivery</time_frame>
    <description>Umbilical-artery blood pH &lt; = 7.05 and base deficit in extracellular fluid &gt; = 12 mmol/liter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Neonates Intubated for Ventilation at Delivery (Primary Outcome Component)</measure>
    <time_frame>Delivery</time_frame>
    <description>Neonatal intubation for ventilation in the delivery room</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of Infants Experiencing Neonatal Encephalopathy (Primary Outcome Component)</measure>
    <time_frame>Delivery through hospital discharge</time_frame>
    <description>Neonatal encephalopathy experienced between delivery and discharge</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of Participants by Delivery Method</measure>
    <time_frame>Delivery</time_frame>
    <description>Method of delivery of the baby: spontaneous, vacuum assisted, forceps, cesarean</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants by Indication for Cesarean</measure>
    <time_frame>At any time from randomization through delivery</time_frame>
    <description>indication for the cesarean delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With an Indication for Forceps or Vacuum Delivery</measure>
    <time_frame>During labor through delivery</time_frame>
    <description>Indication for delivery by forceps or vacuum</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Duration of Labor Post-randomization</measure>
    <time_frame>Onset of Labor through delivery</time_frame>
    <description>Duration of labor in hours after randomization through delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Neonates With Shoulder Dystocia During Delivery</measure>
    <time_frame>Delivery</time_frame>
    <description>Presence of shoulder dystocia during delivery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants With Chorioamnionitis</measure>
    <time_frame>Any time from Randomization through Delivery</time_frame>
    <description>Chorioamnionitis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Who Had a Postpartum Blood Transfusion</measure>
    <time_frame>Delivery through hospital discharge</time_frame>
    <description>Blood transfusion from delivery and through hospital stay until discharge</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Participants Experiencing Postpartum Endometritis</measure>
    <time_frame>Delivery through hospital discharge</time_frame>
    <description>Postpartum endometritis</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Length of Hospital Stay</measure>
    <time_frame>From admission to labor and delivery through hospital discharge</time_frame>
    <description>Days of stay in the hospital</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Infants Admitted to Special Care Nursery</measure>
    <time_frame>Delivery and 1 month of age</time_frame>
    <description>Intermediate care nursery or neonatal intensive care (anything more than well-baby nursery)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Median Apgar Score at 5 Minutes</measure>
    <time_frame>5 minutes after Delivery</time_frame>
    <description>The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Infants With Meconium Aspiration Syndrome</measure>
    <time_frame>Delivery through discharge</time_frame>
    <description>Meconium aspiration syndrome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Infants With a Major Congenital Malformation</measure>
    <time_frame>Delivery</time_frame>
    <description>Major congenital malformation</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">11108</enrollment>
  <condition>Pregnancy</condition>
  <condition>Obstetric Labor</condition>
  <condition>Parturition</condition>
  <arm_group>
    <arm_group_label>Open Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>• Fetal STAN monitor electrode inserted and data available to caregivers</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Masked Group</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>•Fetal STAN monitor electrode inserted, but data masked to the caregivers</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>fetal STAN monitor</intervention_name>
    <description>The STAN monitor is a system for fetal surveillance that displays the FHR, the uterine activity and information resulting from the analysis of the ST segment of the fetal ECG.</description>
    <arm_group_label>Masked Group</arm_group_label>
    <arm_group_label>Open Group</arm_group_label>
    <other_name>STAN S31</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Singleton, cephalic pregnancy

          -  Gestational age at least 36 weeks, 1 day

          -  Cervical dilation of at least 2 cm and no more than 7 cm

          -  Ruptured membranes

        Exclusion Criteria:

          -  Multifetal gestation

          -  Planned cesarean delivery

          -  Need for immediate delivery

          -  Absent variability or sinusoidal pattern at any time, or a Category II fetal heart
             rate pattern with absent variability in the last 20 minutes before randomization

          -  Inability to obtain or maintain an adequate signal within 3 trials of electrode
             placements

          -  Occurrence of any ST event during attempt to obtain adequate signal

          -  Patient pushing in the first stage of labor

          -  Known major fetal anomaly or fetal demise

          -  Previous uterine surgery

          -  Placenta previa on admission

          -  Maternal fever greater than or equal to 38 C or 100.4 F

          -  Active HSV infection

          -  Known HIV or hepatitis infection

          -  Other maternal and fetal contraindications for using the STAN monitor

          -  Enrollment in another labor study

          -  Participation in this trial in a previous pregnancy

          -  No certified or authorized provider available
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Menachem Miodovnik, MD</last_name>
    <role>Study Director</role>
    <affiliation>Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Rebecca Clifton, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>George Washington University Biostatistics Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>George Saade, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Texas</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Michael Belfort, MD</last_name>
    <role>Study Chair</role>
    <affiliation>University of Utah</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of Alabama - Birmingham</name>
      <address>
        <city>Birmingham</city>
        <state>Alabama</state>
        <zip>35429</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Northwestern University</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wayne State University - Hutzel Hospital</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48201</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Columbia University</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10032</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of North Carolina - Chapel Hill</name>
      <address>
        <city>Chapel Hill</city>
        <state>North Carolina</state>
        <zip>17599</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Case Western University</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ohio State University</name>
      <address>
        <city>Columbus</city>
        <state>Ohio</state>
        <zip>43210</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Oregon Health &amp; Science University</name>
      <address>
        <city>Portland</city>
        <state>Oregon</state>
        <zip>97239</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Pittsburgh - Magee Womens Hospital</name>
      <address>
        <city>Pittsburgh</city>
        <state>Pennsylvania</state>
        <zip>15213</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Brown University</name>
      <address>
        <city>Providence</city>
        <state>Rhode Island</state>
        <zip>02905</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas - Galveston</name>
      <address>
        <city>Galveston</city>
        <state>Texas</state>
        <zip>77555</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Texas - Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah Medical Center</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84132</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.bsc.gwu.edu/mfmu</url>
    <description>The public website of the NICHD Maternal Fetal Medicine Units (MFMU) Network</description>
  </link>
  <reference>
    <citation>Rosén KG, Kjellmer I. Changes in the fetal heart rate and ECG during hypoxia. Acta Physiol Scand. 1975 Jan;93(1):59-66.</citation>
    <PMID>1155132</PMID>
  </reference>
  <reference>
    <citation>Rosen KG, Isaksson O. Alterations in the fetal heart rate and ECG correlated to glycogen, creatine phosphate and ATP levels during graded hypoxia. Biol Neonate 1976;30:17-24</citation>
  </reference>
  <reference>
    <citation>Hökegård KH, Eriksson BO, Kjellmer I, Magno R, Rosén KG. Myocardial metabolism in relation to electrocardiographic changes and cardiac function during graded hypoxia in the fetal lamb. Acta Physiol Scand. 1981 Sep;113(1):1-7.</citation>
    <PMID>7315431</PMID>
  </reference>
  <reference>
    <citation>Hökegård KH, Karlsson K, Kjellmer I, Rosén KG. ECG-changes in the fetal lamb during asphyxia in relation to beta-adrenoceptor stimulation and blockade. Acta Physiol Scand. 1979 Feb;105(2):195-203.</citation>
    <PMID>33536</PMID>
  </reference>
  <reference>
    <citation>Dagbjartsson A, Herbertsson G, Stefansson TS, Kjeld M, Lagercrantz H, Rosen KG. Beta-adrenoceptor agonists and hypoxia in sheep fetuses. Acta Physiol Scand. 1989 Oct;137(2):291-9.</citation>
    <PMID>2618763</PMID>
  </reference>
  <reference>
    <citation>Widmark C, Jansson T, Lindecrantz K, Rosén KG. ECG waveform, short term heart rate variability and plasma catecholamine concentrations in response to hypoxia in intrauterine growth retarded guinea-pig fetuses. J Dev Physiol. 1991 Mar;15(3):161-8.</citation>
    <PMID>1940143</PMID>
  </reference>
  <reference>
    <citation>Greene KR, Dawes GS, Lilja H, Rosén KG. Changes in the ST waveform of the fetal lamb electrocardiogram with hypoxemia. Am J Obstet Gynecol. 1982 Dec 15;144(8):950-8.</citation>
    <PMID>7148927</PMID>
  </reference>
  <reference>
    <citation>Rosén KG, Dagbjartsson A, Henriksson BA, Lagercrantz H, Kjellmer I. The relationship between circulating catecholamines and ST waveform in the fetal lamb electrocardiogram during hypoxia. Am J Obstet Gynecol. 1984 May 15;149(2):190-5.</citation>
    <PMID>6720798</PMID>
  </reference>
  <reference>
    <citation>Greene KR, Rosen KG. Long-term ST waveform changes in the ovine fetal electrocardiogram: the relationship to spontaneous labour and intrauterine death. Clin Phys Physiol Meas. 1989;10 Suppl B:33-40.</citation>
    <PMID>2630159</PMID>
  </reference>
  <reference>
    <citation>Widmark C, Hökegård KH, Lagercrantz H, Lilja H, Rosén KG. Electrocardiographic waveform changes and catecholamine responses during acute hypoxia in the immature and mature fetal lamb. Am J Obstet Gynecol. 1989 May;160(5 Pt 1):1245-50.</citation>
    <PMID>2729402</PMID>
  </reference>
  <reference>
    <citation>Gelli MG, Bergström J, Hultman E, Thalme B. Heart muscle and plasma electrolytes in normal and glucose-loaded rabbit foetuses under anoxia. Acta Obstet Gynecol Scand. 1969;48(1):34-55.</citation>
    <PMID>5372122</PMID>
  </reference>
  <reference>
    <citation>Rosén KG, Hökegård KH, Kjellmer I. A study of the relationship between the electrocardiogram and hemodynamics in the fetal lamb during asphyxia. Acta Physiol Scand. 1976 Nov;98(3):275-84.</citation>
    <PMID>11642</PMID>
  </reference>
  <reference>
    <citation>Watanabe T, Okamura K, Tanigawara S, Shintaku Y, Akagi K, Endo H, Yajima A. Change in electrocardiogram T-wave amplitude during umbilical cord compression is predictive of fetal condition in sheep. Am J Obstet Gynecol. 1992 Jan;166(1 Pt 1):246-55.</citation>
    <PMID>1733202</PMID>
  </reference>
  <reference>
    <citation>Westgate JA, Bennet L, Brabyn C, Williams CE, Gunn AJ. ST waveform changes during repeated umbilical cord occlusions in near-term fetal sheep. Am J Obstet Gynecol. 2001 Mar;184(4):743-51.</citation>
    <PMID>11262482</PMID>
  </reference>
  <reference>
    <citation>Westgate J, Harris M, Curnow JS, Greene KR. Plymouth randomized trial of cardiotocogram only versus ST waveform plus cardiotocogram for intrapartum monitoring in 2400 cases. Am J Obstet Gynecol. 1993 Nov;169(5):1151-60.</citation>
    <PMID>8238177</PMID>
  </reference>
  <reference>
    <citation>Amer-Wåhlin I, Hellsten C, Norén H, Hagberg H, Herbst A, Kjellmer I, Lilja H, Lindoff C, Månsson M, Mårtensson L, Olofsson P, Sundström A, Marsál K. Cardiotocography only versus cardiotocography plus ST analysis of fetal electrocardiogram for intrapartum fetal monitoring: a Swedish randomised controlled trial. Lancet. 2001 Aug 18;358(9281):534-8.</citation>
    <PMID>11520523</PMID>
  </reference>
  <reference>
    <citation>Ojala K, Vääräsmäki M, Mäkikallio K, Valkama M, Tekay A. A comparison of intrapartum automated fetal electrocardiography and conventional cardiotocography--a randomised controlled study. BJOG. 2006 Apr;113(4):419-23.</citation>
    <PMID>16553653</PMID>
  </reference>
  <reference>
    <citation>Vayssière C, David E, Meyer N, Haberstich R, Sebahoun V, Roth E, Favre R, Nisand I, Langer B. A French randomized controlled trial of ST-segment analysis in a population with abnormal cardiotocograms during labor. Am J Obstet Gynecol. 2007 Sep;197(3):299.e1-6.</citation>
    <PMID>17826428</PMID>
  </reference>
  <reference>
    <citation>Norén H, Amer-Wåhlin I, Hagberg H, Herbst A, Kjellmer I, Marşál K, Olofsson P, Rosén KG. Fetal electrocardiography in labor and neonatal outcome: data from the Swedish randomized controlled trial on intrapartum fetal monitoring. Am J Obstet Gynecol. 2003 Jan;188(1):183-92.</citation>
    <PMID>12548215</PMID>
  </reference>
  <reference>
    <citation>Neilson JP. Fetal electrocardiogram (ECG) for fetal monitoring during labour. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD000116. Review. Update in: Cochrane Database Syst Rev. 2012;4:CD000116.</citation>
    <PMID>16855950</PMID>
  </reference>
  <reference>
    <citation>Amer-Wåhlin I, Bördahl P, Eikeland T, Hellsten C, Norén H, Sörnes T, Rosén KG. ST analysis of the fetal electrocardiogram during labor: Nordic observational multicenter study. J Matern Fetal Neonatal Med. 2002 Oct;12(4):260-6.</citation>
    <PMID>12572595</PMID>
  </reference>
  <reference>
    <citation>Luttkus AK, Norén H, Stupin JH, Blad S, Arulkumaran S, Erkkola R, Hagberg H, Lenstrup C, Visser GH, Tamazian O, Yli B, Rosén KG, Dudenhausen JW. Fetal scalp pH and ST analysis of the fetal ECG as an adjunct to CTG. A multi-center, observational study. J Perinat Med. 2004;32(6):486-94.</citation>
    <PMID>15576269</PMID>
  </reference>
  <reference>
    <citation>Kwee A, van der Hoorn-van den Beld CW, Veerman J, Dekkers AH, Visser GH. STAN S21 fetal heart monitor for fetal surveillance during labor: an observational study in 637 patients. J Matern Fetal Neonatal Med. 2004 Jun;15(6):400-7.</citation>
    <PMID>15280112</PMID>
  </reference>
  <reference>
    <citation>Vayssiere C, Haberstich R, Sebahoun V, David E, Roth E, Langer B. Fetal electrocardiogram ST-segment analysis and prediction of neonatal acidosis. Int J Gynaecol Obstet. 2007 May;97(2):110-4. Epub 2007 Mar 26.</citation>
    <PMID>17368461</PMID>
  </reference>
  <reference>
    <citation>Norén H, Blad S, Carlsson A, Flisberg A, Gustavsson A, Lilja H, Wennergren M, Hagberg H. STAN in clinical practice--the outcome of 2 years of regular use in the city of Gothenburg. Am J Obstet Gynecol. 2006 Jul;195(1):7-15. Epub 2006 Apr 27.</citation>
    <PMID>16643829</PMID>
  </reference>
  <reference>
    <citation>Ross MG, Devoe LD, Rosen KG. ST-segment analysis of the fetal electrocardiogram improves fetal heart rate tracing interpretation and clinical decision making. J Matern Fetal Neonatal Med. 2004 Mar;15(3):181-5.</citation>
    <PMID>15280144</PMID>
  </reference>
  <reference>
    <citation>Devoe LD, Ross M, Wilde C, Beal M, Lysikewicz A, Maier J, Vines V, Amer-Wåhlin I, Lilja H, Norén H, Maulik D. United States multicenter clinical usage study of the STAN 21 electronic fetal monitoring system. Am J Obstet Gynecol. 2006 Sep;195(3):729-34.</citation>
    <PMID>16949404</PMID>
  </reference>
  <reference>
    <citation>Macones GA, Hankins GD, Spong CY, Hauth J, Moore T. The 2008 National Institute of Child Health and Human Development workshop report on electronic fetal monitoring: update on definitions, interpretation, and research guidelines. J Obstet Gynecol Neonatal Nurs. 2008 Sep-Oct;37(5):510-5. doi: 10.1111/j.1552-6909.2008.00284.x.</citation>
    <PMID>18761565</PMID>
  </reference>
  <reference>
    <citation>Siggaard-Andersen O. An acid-base chart for arterial blood with normal and pathophysiological reference areas. Scand J Clin Lab Invest. 1971 May;27(3):239-45.</citation>
    <PMID>5581186</PMID>
  </reference>
  <reference>
    <citation>Shankaran S, Laptook AR, Ehrenkranz RA, Tyson JE, McDonald SA, Donovan EF, Fanaroff AA, Poole WK, Wright LL, Higgins RD, Finer NN, Carlo WA, Duara S, Oh W, Cotten CM, Stevenson DK, Stoll BJ, Lemons JA, Guillet R, Jobe AH; National Institute of Child Health and Human Development Neonatal Research Network. Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005 Oct 13;353(15):1574-84.</citation>
    <PMID>16221780</PMID>
  </reference>
  <reference>
    <citation>Bloom SL, Spong CY, Thom E, Varner MW, Rouse DJ, Weininger S, Ramin SM, Caritis SN, Peaceman A, Sorokin Y, Sciscione A, Carpenter M, Mercer B, Thorp J, Malone F, Harper M, Iams J, Anderson G; National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Fetal pulse oximetry and cesarean delivery. N Engl J Med. 2006 Nov 23;355(21):2195-202.</citation>
    <PMID>17124017</PMID>
  </reference>
  <reference>
    <citation>Jennison C, Turnbull BW. Statistical approaches to interim monitoring of medical trials: a review and commentary. Statist. Sci. 1990; 229-317.</citation>
  </reference>
  <reference>
    <citation>Demets DL. Practical aspects in data monitoring: a brief review. Stat Med. 1987 Oct-Nov;6(7):753-60. Review.</citation>
    <PMID>3321314</PMID>
  </reference>
  <reference>
    <citation>Pocock SJ. Group sequential methods in the design and analysis of clinical trials. Biometrika 1977; 64: 191-199.</citation>
  </reference>
  <reference>
    <citation>O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979 Sep;35(3):549-56.</citation>
    <PMID>497341</PMID>
  </reference>
  <reference>
    <citation>Lan KK, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983; 70: 659-63.</citation>
  </reference>
  <reference>
    <citation>Lan KK, Wittes J. The B-value: a tool for monitoring data. Biometrics. 1988 Jun;44(2):579-85.</citation>
    <PMID>3390511</PMID>
  </reference>
  <reference>
    <citation>Pocock SJ. When to stop a clinical trial. BMJ. 1992 Jul 25;305(6847):235-40.</citation>
    <PMID>1392832</PMID>
  </reference>
  <reference>
    <citation>Stallones RA. The use and abuse of subgroup analysis in epidemiological research. Prev Med. 1987 Mar;16(2):183-94.</citation>
    <PMID>3295858</PMID>
  </reference>
  <reference>
    <citation>Yusuf S, Wittes J, Probstfield J, Tyroler HA. Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. JAMA. 1991 Jul 3;266(1):93-8.</citation>
    <PMID>2046134</PMID>
  </reference>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>May 25, 2010</study_first_submitted>
  <study_first_submitted_qc>May 25, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 26, 2010</study_first_posted>
  <results_first_submitted>February 8, 2019</results_first_submitted>
  <results_first_submitted_qc>April 2, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">April 5, 2019</results_first_posted>
  <last_update_submitted>July 11, 2019</last_update_submitted>
  <last_update_submitted_qc>July 11, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>STAN</keyword>
  <keyword>Fetal monitoring</keyword>
  <keyword>Fetal acidosis</keyword>
  <keyword>Fetal heart rate monitoring</keyword>
  <keyword>Perinatology</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>The dataset will be shared per NIH policy after the completion and publication of the main analyses. Requests for datasets can be sent to mfmudatasets@bsc.gwu.edu</ipd_description>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Open Group</title>
          <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
        </group>
        <group group_id="P2">
          <title>Masked Group</title>
          <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5532"/>
                <participants group_id="P2" count="5576"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="5488"/>
                <participants group_id="P2" count="5529"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="47"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Randomization error</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Declined to continue participation</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="13"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="22"/>
                <participants group_id="P2" count="24"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Technical problems</title>
              <participants_list>
                <participants group_id="P1" count="7"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Staff error</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Ineligible</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Open Group</title>
          <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
        </group>
        <group group_id="B2">
          <title>Masked Group</title>
          <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5532"/>
            <count group_id="B2" value="5576"/>
            <count group_id="B3" value="11108"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5532"/>
                    <count group_id="B2" value="5576"/>
                    <count group_id="B3" value="11108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.4" spread="5.9"/>
                    <measurement group_id="B2" value="27.2" spread="5.8"/>
                    <measurement group_id="B3" value="27.3" spread="5.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5532"/>
                    <count group_id="B2" value="5576"/>
                    <count group_id="B3" value="11108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="5532"/>
                    <measurement group_id="B2" value="5576"/>
                    <measurement group_id="B3" value="11108"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race/Ethnicity, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5532"/>
                    <count group_id="B2" value="5576"/>
                    <count group_id="B3" value="11108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Black</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1326"/>
                    <measurement group_id="B2" value="1350"/>
                    <measurement group_id="B3" value="2676"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3297"/>
                    <measurement group_id="B2" value="3281"/>
                    <measurement group_id="B3" value="6578"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="B1" value="909"/>
                    <measurement group_id="B2" value="945"/>
                    <measurement group_id="B3" value="1854"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Week of pregnancy at randomization</title>
          <units>weeks</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5532"/>
                    <count group_id="B2" value="5576"/>
                    <count group_id="B3" value="11108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.4" spread="1.2"/>
                    <measurement group_id="B2" value="39.4" spread="1.2"/>
                    <measurement group_id="B3" value="39.4" spread="1.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body-mass index before pregnancy</title>
          <population>Pre-pregnancy BMI was not able to be obtained for all participants.</population>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5498"/>
                    <count group_id="B2" value="5533"/>
                    <count group_id="B3" value="11031"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="27.4" spread="7.2"/>
                    <measurement group_id="B2" value="27.4" spread="7.0"/>
                    <measurement group_id="B3" value="27.4" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Educational level</title>
          <population>Schooling based on self report. Unable to obtain for all participants.</population>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5484"/>
                    <count group_id="B2" value="5516"/>
                    <count group_id="B3" value="11000"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.8" spread="2.6"/>
                    <measurement group_id="B2" value="12.8" spread="2.7"/>
                    <measurement group_id="B3" value="12.8" spread="2.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cervical dilation at randomization</title>
          <units>centimeters</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5532"/>
                    <count group_id="B2" value="5576"/>
                    <count group_id="B3" value="11108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5" lower_limit="4" upper_limit="6"/>
                    <measurement group_id="B2" value="5" lower_limit="4" upper_limit="6"/>
                    <measurement group_id="B3" value="5" lower_limit="4" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Type of labor</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Spontaneous</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5532"/>
                    <count group_id="B2" value="5576"/>
                    <count group_id="B3" value="11108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2259"/>
                    <measurement group_id="B2" value="2311"/>
                    <measurement group_id="B3" value="4570"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Induced</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5532"/>
                    <count group_id="B2" value="5576"/>
                    <count group_id="B3" value="11108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3273"/>
                    <measurement group_id="B2" value="3265"/>
                    <measurement group_id="B3" value="6538"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Nulliparous</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="5532"/>
                    <count group_id="B2" value="5576"/>
                    <count group_id="B3" value="11108"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="2354"/>
                    <measurement group_id="B2" value="2373"/>
                    <measurement group_id="B3" value="4727"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Number of Participants With Primary Composite Outcome</title>
        <description>Composite primary outcome of intrapartum fetal death, neonatal death, Apgar score &lt;=3 at 5 minutes, neonatal seizure, umbilical artery blood pH &lt;= 7.05 with base deficit &gt;=12 mmol/L in extra-cellular fluid, intubation for ventilation at delivery, neonatal encelphalopathy</description>
        <time_frame>From Delivery through 1 month of age</time_frame>
        <population>Umbilical cord artery blood was not able to be obtained from all participants.</population>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Primary Composite Outcome</title>
          <description>Composite primary outcome of intrapartum fetal death, neonatal death, Apgar score &lt;=3 at 5 minutes, neonatal seizure, umbilical artery blood pH &lt;= 7.05 with base deficit &gt;=12 mmol/L in extra-cellular fluid, intubation for ventilation at delivery, neonatal encelphalopathy</description>
          <population>Umbilical cord artery blood was not able to be obtained from all participants.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="52"/>
                    <measurement group_id="O2" value="40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>Analysis on primary composite outcome as a whole.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.20</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.31</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.87</ci_lower_limit>
            <ci_upper_limit>1.98</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Intrapartum Fetal Deaths (Primary Outcome Component)</title>
        <description>Death of the fetus during the intrapartum period.</description>
        <time_frame>During labor and through delivery of the baby</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Intrapartum Fetal Deaths (Primary Outcome Component)</title>
          <description>Death of the fetus during the intrapartum period.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Neonatal Deaths (Primary Outcome Component)</title>
        <description>Death of the newborn between delivery and1 month of age</description>
        <time_frame>Delivery through1 month of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Neonatal Deaths (Primary Outcome Component)</title>
          <description>Death of the newborn between delivery and1 month of age</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.37</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>3.02</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.31</ci_lower_limit>
            <ci_upper_limit>29.1</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Infants With Apgar Score &lt; = 3 at 5 Minutes (Primary Outcome Component)</title>
        <description>The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score. The lowest score is 0, the highest score is 10.</description>
        <time_frame>5 minutes after delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants With Apgar Score &lt; = 3 at 5 Minutes (Primary Outcome Component)</title>
          <description>The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score. The lowest score is 0, the highest score is 10.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>2.86</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>1.13</ci_lower_limit>
            <ci_upper_limit>7.24</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Infants Who Experienced Neonatal Seizure (Primary Outcome Component)</title>
        <description>Number of infants who experienced Neonatal Seizure</description>
        <time_frame>Birth through hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants Who Experienced Neonatal Seizure (Primary Outcome Component)</title>
          <description>Number of infants who experienced Neonatal Seizure</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>1.0</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.76</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.17</ci_lower_limit>
            <ci_upper_limit>3.38</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Infants With Umbilical-artery Blood pH &lt; = 7.05 and Base Deficit in Extracellular Fluid &gt; = 12 mmol/Liter (Primary Outcome Component)</title>
        <description>Umbilical-artery blood pH &lt; = 7.05 and base deficit in extracellular fluid &gt; = 12 mmol/liter</description>
        <time_frame>Delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants With Umbilical-artery Blood pH &lt; = 7.05 and Base Deficit in Extracellular Fluid &gt; = 12 mmol/Liter (Primary Outcome Component)</title>
          <description>Umbilical-artery blood pH &lt; = 7.05 and base deficit in extracellular fluid &gt; = 12 mmol/liter</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5362"/>
                <count group_id="O2" value="5359"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.13</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.37</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.10</ci_lower_limit>
            <ci_upper_limit>1.41</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Neonates Intubated for Ventilation at Delivery (Primary Outcome Component)</title>
        <description>Neonatal intubation for ventilation in the delivery room</description>
        <time_frame>Delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Neonates Intubated for Ventilation at Delivery (Primary Outcome Component)</title>
          <description>Neonatal intubation for ventilation in the delivery room</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42"/>
                    <measurement group_id="O2" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.07</p_value>
            <method>Chi-squared</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>1.57</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.97</ci_lower_limit>
            <ci_upper_limit>2.54</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Number of Infants Experiencing Neonatal Encephalopathy (Primary Outcome Component)</title>
        <description>Neonatal encephalopathy experienced between delivery and discharge</description>
        <time_frame>Delivery through hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants Experiencing Neonatal Encephalopathy (Primary Outcome Component)</title>
          <description>Neonatal encephalopathy experienced between delivery and discharge</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>1.0</p_value>
            <method>Fisher Exact</method>
            <param_type>Risk Ratio (RR)</param_type>
            <param_value>0.81</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.22</ci_lower_limit>
            <ci_upper_limit>3.00</ci_upper_limit>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants by Delivery Method</title>
        <description>Method of delivery of the baby: spontaneous, vacuum assisted, forceps, cesarean</description>
        <time_frame>Delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>• Fetal STAN monitor electrode inserted and data available to caregivers
fetal STAN monitor: The STAN monitor is a system for fetal surveillance that displays the FHR, the uterine activity and information resulting from the analysis of the ST segment of the fetal ECG.</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>•Fetal STAN monitor electrode inserted, but data masked to the caregivers
fetal STAN monitor: The STAN monitor is a system for fetal surveillance that displays the FHR, the uterine activity and information resulting from the analysis of the ST segment of the fetal ECG.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants by Delivery Method</title>
          <description>Method of delivery of the baby: spontaneous, vacuum assisted, forceps, cesarean</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Spontaneous</title>
                  <measurement_list>
                    <measurement group_id="O1" value="4269"/>
                    <measurement group_id="O2" value="4348"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Forceps</title>
                  <measurement_list>
                    <measurement group_id="O1" value="128"/>
                    <measurement group_id="O2" value="103"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Vacuum-Assisted</title>
                  <measurement_list>
                    <measurement group_id="O1" value="201"/>
                    <measurement group_id="O2" value="224"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Cesarean</title>
                  <measurement_list>
                    <measurement group_id="O1" value="934"/>
                    <measurement group_id="O2" value="901"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.17</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants by Indication for Cesarean</title>
        <description>indication for the cesarean delivery</description>
        <time_frame>At any time from randomization through delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants by Indication for Cesarean</title>
          <description>indication for the cesarean delivery</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="934"/>
                <count group_id="O2" value="901"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Fetal Indication</title>
                  <measurement_list>
                    <measurement group_id="O1" value="287"/>
                    <measurement group_id="O2" value="298"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Dystocia</title>
                  <measurement_list>
                    <measurement group_id="O1" value="621"/>
                    <measurement group_id="O2" value="583"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Other</title>
                  <measurement_list>
                    <measurement group_id="O1" value="26"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.45</p_value>
            <p_value_desc>The p value was calculated based on the entire study cohort.</p_value_desc>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With an Indication for Forceps or Vacuum Delivery</title>
        <description>Indication for delivery by forceps or vacuum</description>
        <time_frame>During labor through delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With an Indication for Forceps or Vacuum Delivery</title>
          <description>Indication for delivery by forceps or vacuum</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="329"/>
                <count group_id="O2" value="327"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Fetal indication</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="225"/>
                    <measurement group_id="O2" value="218"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Dystocia</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="95"/>
                    <measurement group_id="O2" value="101"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Other</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Median Duration of Labor Post-randomization</title>
        <description>Duration of labor in hours after randomization through delivery</description>
        <time_frame>Onset of Labor through delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Median Duration of Labor Post-randomization</title>
          <description>Duration of labor in hours after randomization through delivery</description>
          <units>Hours</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.8" lower_limit="2.1" upper_limit="6.4"/>
                    <measurement group_id="O2" value="3.9" lower_limit="2.2" upper_limit="6.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.32</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Neonates With Shoulder Dystocia During Delivery</title>
        <description>Presence of shoulder dystocia during delivery</description>
        <time_frame>Delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Neonates With Shoulder Dystocia During Delivery</title>
          <description>Presence of shoulder dystocia during delivery</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="141"/>
                    <measurement group_id="O2" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.35</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants With Chorioamnionitis</title>
        <description>Chorioamnionitis</description>
        <time_frame>Any time from Randomization through Delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants With Chorioamnionitis</title>
          <description>Chorioamnionitis</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="286"/>
                    <measurement group_id="O2" value="269"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.40</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Who Had a Postpartum Blood Transfusion</title>
        <description>Blood transfusion from delivery and through hospital stay until discharge</description>
        <time_frame>Delivery through hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>• Fetal STAN monitor electrode inserted and data available to caregivers
fetal STAN monitor: The STAN monitor is a system for fetal surveillance that displays the FHR, the uterine activity and information resulting from the analysis of the ST segment of the fetal ECG.</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>•Fetal STAN monitor electrode inserted, but data masked to the caregivers
fetal STAN monitor: The STAN monitor is a system for fetal surveillance that displays the FHR, the uterine activity and information resulting from the analysis of the ST segment of the fetal ECG.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Who Had a Postpartum Blood Transfusion</title>
          <description>Blood transfusion from delivery and through hospital stay until discharge</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80"/>
                    <measurement group_id="O2" value="74"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.59</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Participants Experiencing Postpartum Endometritis</title>
        <description>Postpartum endometritis</description>
        <time_frame>Delivery through hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>• Fetal STAN monitor electrode inserted and data available to caregivers
fetal STAN monitor: The STAN monitor is a system for fetal surveillance that displays the FHR, the uterine activity and information resulting from the analysis of the ST segment of the fetal ECG.</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>•Fetal STAN monitor electrode inserted, but data masked to the caregivers
fetal STAN monitor: The STAN monitor is a system for fetal surveillance that displays the FHR, the uterine activity and information resulting from the analysis of the ST segment of the fetal ECG.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Participants Experiencing Postpartum Endometritis</title>
          <description>Postpartum endometritis</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71"/>
                    <measurement group_id="O2" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.19</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Median Length of Hospital Stay</title>
        <description>Days of stay in the hospital</description>
        <time_frame>From admission to labor and delivery through hospital discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Median Length of Hospital Stay</title>
          <description>Days of stay in the hospital</description>
          <units>Days</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2" lower_limit="2" upper_limit="2"/>
                    <measurement group_id="O2" value="2" lower_limit="2" upper_limit="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.77</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Infants Admitted to Special Care Nursery</title>
        <description>Intermediate care nursery or neonatal intensive care (anything more than well-baby nursery)</description>
        <time_frame>Delivery and 1 month of age</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants Admitted to Special Care Nursery</title>
          <description>Intermediate care nursery or neonatal intensive care (anything more than well-baby nursery)</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="498"/>
                    <measurement group_id="O2" value="470"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.28</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Median Apgar Score at 5 Minutes</title>
        <description>The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score.</description>
        <time_frame>5 minutes after Delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Median Apgar Score at 5 Minutes</title>
          <description>The Apgar score is a simple method of quickly assessing the health and vital signs of a newborn baby created by and named after Dr. Virginia Apgar. Apgar testing assesses Appearance, Pulse, Grimace and Activity in a newborn and is typically done at one and five minutes after a baby is born, and it may be repeated at 10, 15, and 20 minutes if the score is low. The five criteria are each scored as 0, 1, or 2 (two being the best), and the total score is calculated by then adding the five values obtained. Agar scores of 0-3 are critically low, 4-6 are below normal, and indicate that the baby likely requires medical intervention, scores of 7+ are considered normal. The lower the Apgar score, the more alert the medical team should be to the possibility of the baby requiring intervention. Some components of the Apgar score are subjective, and there are cases in which a baby requires urgent medical treatment despite having a high Apgar score.</description>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9" lower_limit="9" upper_limit="9"/>
                    <measurement group_id="O2" value="9" lower_limit="9" upper_limit="9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.54</p_value>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Infants With Meconium Aspiration Syndrome</title>
        <description>Meconium aspiration syndrome</description>
        <time_frame>Delivery through discharge</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants With Meconium Aspiration Syndrome</title>
          <description>Meconium aspiration syndrome</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="20"/>
                    <measurement group_id="O2" value="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.98</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Infants With a Major Congenital Malformation</title>
        <description>Major congenital malformation</description>
        <time_frame>Delivery</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Open Group</title>
            <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
          </group>
          <group group_id="O2">
            <title>Masked Group</title>
            <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Infants With a Major Congenital Malformation</title>
          <description>Major congenital malformation</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5532"/>
                <count group_id="O2" value="5576"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="38"/>
                    <measurement group_id="O2" value="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>.05</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Data on adverse events was collected on a continuous basis for each participant from the time of randomization up through the time of hospital discharge.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Open Group</title>
          <description>S31 monitors in the open mode displayed ECG ST-segment information intended for use when uncertain fetal heart-rate patterns were detected. Management of the labor and delivery for women in this group was dictated by the ST-segment analysis guidelines</description>
        </group>
        <group group_id="E2">
          <title>Masked Group</title>
          <description>The masked S31 monitors functioned as conventional electronic fetal heart-rate monitors. The care of patients in the masked group was managed at the discretion of the attending physician or midwife.</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="35" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="5576"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Congenital malformation</sub_title>
                <counts group_id="E1" subjects_affected="11" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5576"/>
              </event>
              <event>
                <sub_title>Neonatal death</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5576"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Maternal Infection (bacteremia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5576"/>
              </event>
              <event>
                <sub_title>Scalp abscess/pustules (neonatal)</sub_title>
                <description>From site of fetal ECG clip</description>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5576"/>
              </event>
              <event>
                <sub_title>Infection/sepsis (neonate)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="5576"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Maternal Seizure (eclampsia)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5576"/>
              </event>
              <event>
                <sub_title>Neonatal Encephalopathy</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5576"/>
              </event>
              <event>
                <sub_title>Neonatal Seizure</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5576"/>
              </event>
              <event>
                <sub_title>Brachial plexus injury</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5576"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Postpartum Hemorrhage</sub_title>
                <counts group_id="E1" subjects_affected="7" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="4" subjects_at_risk="5576"/>
              </event>
              <event>
                <sub_title>Uterine Rupture</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5576"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute Respiratory Distress Syndrome</sub_title>
                <description>Neonatal RDS</description>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5576"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5576"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Subgaleal hematoma (neonate)</sub_title>
                <counts group_id="E1" subjects_affected="3" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="5576"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>1</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="5532"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5576"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There IS an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Rebecca Clifton, Ph.D.</name_or_title>
      <organization>The George Washington University Biostatistics Center</organization>
      <phone>301-881-9260</phone>
      <email>rclifton@bsc.gwu.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

